Cartilage–hair hypoplasia

From WikiMD's Medical Encyclopedia

Cartilage–hair hypoplasia (CHH) is a rare genetic disorder characterized by short stature, fine and sparse hair, and immunodeficiency. It is a form of skeletal dysplasia and is associated with anemia and an increased risk of certain cancers.

Genetics[edit]

CHH is caused by mutations in the RMRP gene, which is located on chromosome 9. This gene is responsible for encoding a non-coding RNA component of the mitochondrial RNA processing endoribonuclease. The disorder is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene to be affected.

Clinical Features[edit]

Individuals with CHH typically present with short stature due to metaphyseal dysplasia, which affects the growth of long bones. Hair is often sparse, fine, and light-colored. The condition is also associated with immunodeficiency, leading to increased susceptibility to infections. Some individuals may develop anemia and have an increased risk of developing certain types of cancer, such as lymphoma and basal cell carcinoma.

Diagnosis[edit]

Diagnosis of CHH is based on clinical features, family history, and genetic testing to identify mutations in the RMRP gene. Radiographic imaging can reveal characteristic skeletal abnormalities, and blood tests can assess immune function and detect anemia.

Management[edit]

Management of CHH involves a multidisciplinary approach, including regular monitoring of growth and development, management of infections, and surveillance for malignancies. Growth hormone therapy may be considered in some cases to improve growth. Bone marrow transplantation may be an option for individuals with severe immunodeficiency.

Epidemiology[edit]

CHH is most commonly found in the Amish and Finnish populations, but it can occur in any ethnic group. The prevalence is estimated to be 1 in 23,000 in the Finnish population.

See also[edit]

External links[edit]





Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.